Login / Signup

Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.

Wen-Kuan HuangShih-Chiang HuangChien-Ming ChenPo Hung LinChiao-En WuCheng-Keng ChuangChun-Nan Yeh
Published in: JCO precision oncology (2023)
Keyphrases
  • single cell
  • rectal cancer
  • cell therapy
  • cell cycle
  • locally advanced
  • nucleic acid
  • stem cells
  • squamous cell carcinoma
  • radiation therapy